Medicaid Bulletin
SPECIAL BULLETIN COVID-19 #104: Archived Dental Webinars Available
The North Carolina Department of Health and Human Services and the NC Area Health Education Center are partnering in a free webinar series, DHHS COVID-19 Guidance for Dental Professionals, designed to support dental providers during the COVID-19 pandemic.
Billing Code Update
North Carolina Medicaid has received calls concerning claim denials for some services provided by nurse practitioners and physician assistants.
SPECIAL BULLETIN COVID-19 #103: Telehealth and Virtual Patient Communications Clinical Policy Modifications - Nursing Facility Care
This bulletin replaces SPECIAL BULLETIN COVID-19 #79 in its entirety. NC Medicaid has temporarily modified its Telemedicine and Telepsychiatry Clinical Coverage Policy to better enable the delivery of remote care to Medicaid beneficiaries.
SPECIAL BULLETIN COVID-19 #102: Laboratory Codes for Coronavirus (COVID-19) Testing
The Centers for Medicare & Medicaid Services (CMS) and the American Medical Association have announced the release of several new codes to report testing for active cases of Coronavirus (COVID-19) as well as detection of antibodies.
SPECIAL BULLETIN COVID-19 #101: Medicaid Providers May Be Eligible for Federal Funding
CARES Act Provider Relief Fund Webcast, Information for Medicaid Providers and a Checklist for Medicaid Providers Eligible for Federal Relief.
Emapalumab-lzsg Injection, for Intravenous Use (Gamifant™) HCPCS code J9210: Billing Guidelines
Effective with date of service Dec. 28, 2019, the Medicaid and NC Health Choice programs cover emapalumab-lzsg injection, for intravenous use (Gamifant™) for use in the Physician Administered Drug Program (PADP) outpatient hospital setting (only) when billed with HCPCS code J9210 - Injection, emapalumab-lzsg, 1 mg.
Meloxicam Injection, for Intravenous Use (Anjeso™) HCPCS Code J3490: Billing Guidelines
Effective with date of service April 7, 2020, the Medicaid and NC Health Choice programs cover meloxicam injection, for intravenous use (Anjeso™) for use in the Physician Administered Drug Program (PADP) when billed with HCPCS code J3490 - Unclassified drugs.
Sacituzumab Govitecan-hziy for Injection, for Intravenous Use (Trodelvy™) HCPCS Code J9999: Billing Guidelines
Effective with date of service April 23, 2020, the Medicaid and NC Health Choice programs cover sacituzumab govitecan-hziy for injection, for intravenous use (Trodelvy™) for use in the Physician Administered Drug Program (PADP) when billed with HCPCS code J9999 - Not otherwise classified, antineoplastic drugs.
SPECIAL BULLETIN COVID-19 #100: Hospice Provider COVID-19 Rate Structure Clarifications
NC Medicaid has implemented COVID-19 rate increase functionality to reimburse hospice care provided in a skilled nursing facility (SNF) designated as a “SNF COVID-Outbreak site” or “SNF COVID-Response site” in a ratio consistent with how hospice care is reimbursed in all other SNFs.
SPECIAL BULLETIN COVID-19 #99: North Carolina General Assembly Mandates Temporary 5% Rate Increase for Certain Medicaid Providers
Per Section 4.6 of the North Carolina General Assembly’s recently approved Session Law 2020-4 (House Bill 1043), NC Medicaid is implementing a 5% rate increase for all Fee-For-Service (FFS) Medicaid providers who had not yet received a 5% increase during the COVID-19 public health emergency.
Medicaid Bulletin Monthly Digest
Articles beginning January 2018 are available in the blog format.
Share this page: